Human Recombinant EGF G5021
From ToxBankWiki
Human Recombinant EGF G5021
Human Recombinant Epidermal Growth Factor (G5021)
Molecular Description
Molecular Weight | 6.2kDa |
Glycosylation |
Biological Source
Name | E. Coli |
Recombinant or animal source | Recombinant. |
Characterisation Data
PAGE with antibodies | |
Cell culture testing e.g. growth promotion, cytokine expression |
Quality Control Parameters
Biological assay/activity | Biological Activity: The ED50 for rhEGF, i.e., the concentration of factor that produces one-half the maximal response, isdetermined in a proliferation bioassay using BALB/c 3T3 fibroblasts in serum-free medium and the CellTiter 96® AQueousNon-Radioactive Cell Proliferation Assay (Cat.# G5421). The ED50 value obtained is reported on the Product InformationLabel affixed to this document.Specific Activity: An international reference standard 91/530 for recombinant EGF, provided by the National Institute forBiological Standards and Controls, is run in parallel with each batch of rhEGF and used to assign the specific activity. |
Company | Product Link |
---|---|
Promega | Promega(G5021) |
Publications | |
SEURAT Protocols | Search for Protocols in the ToxBank Data Warehouse |
SEURAT Data | Search for Data in the ToxBank Data Warehouse |
Other Links |